SDHB and neoplasm: Importantly, this data would suggest that the approach to clinical surveillance should be tailored to the SDHx subunit gene affected, as recent studies would suggest a higher risk of PPGL (and possibly of synchronous and multifocal tumours) with SDHB gene mutations.